Sara H. Katsanis is an Instructor in Science & Society at Duke University who joined Duke in 2009. Her research focuses on policy options for genetic testing applications in medicine and law enforcement and how genetic technologies affect individuals. She has explored direct-to-consumer genetic testing, pharmacogenetics drug labeling, familial searching of CODIS, and surreptitious collection of DNA. She is also delving into policy options for the applications of kinship analyses to identify victims of human trafficking and adoption fraud through the Kenan Creative Collaboratory, Science, Ethics, Identity and Human Rights (SEIHR).
Katsanis received a MS in Medical Genetics from Brunel University in 1997 having completed her research thesis at Imperial College School of Medicine at St. Mary’s in London, UK. From 1998-2002, she worked in Houston, TX, first as a DNA Analyst in the forensic laboratory at the Harris County Medical Examiner’s Office, then as an Associate Scientist managing the genotyping facility at Lexicon Genetics, Inc. In 2002, she joined Johns Hopkins University in Baltimore, MD as Laboratory Manager for the DNA Diagnostic Laboratory, responsible for oversight and supervision of clinical diagnostic testing. In 2006, Katsanis began working with the Genetics & Public Policy Center within the Berman Institute of Bioethics at Johns Hopkins in Washington, DC. She contributed to the Center’s efforts to address legal, ethics, and policy issues related to human reproductive genetic technologies, genetic testing quality and oversight, and public engagement in genetic testing and research.
Perspectives on genetic and genomic technologies in an academic medical center: The Duke experience. Katsanis SH, Minear M, Vorderstrasse A, Yang N, Reeves J, Rakhra-Burris, Cook-Deegan R, Ginsburg, GS, Simmons LA. (2015) Journal of Personalized Medicine, 5(2):67-82
Preliminary Perspectives on DNA Collection in Anti-Human Trafficking Efforts. Katsanis SH, Kim J, Minear MA, Chandrasekharan S, Wagner JK, Recent Adv DNA Gene Seq. 2015 Feb 16;. Abstract
DNA in immigration and human trafficking. Katsanis SH and Kim J. Forensic DNA Applications: An Interdisciplinary Perspective, CRC Taylor and Francis, Chapter 22 [Jan 31, 2014, commissioned].
Managing incidental genomic findings in clinical trials: Fulfillment of the principle of justice. Dal-Ré R, Katsanis N, Katsanis S, Parker LS, Ayuso C, PLOS Medicine, 2014; 11(1):e1001584.
Educating future providers of personalized medicine. Katsanis SH, Dungan J, Gilliss C, Ginsburg GS, North Carolina Medical Journal. 2013; 74(6):491-492.
Molecular genetic testing and the future of clinical genomics. Katsanis SH, Katsanis N, Nat Rev Genet. 2013 Jun;14(6):415-26. Abstract
Personal DNA Testing in College Classrooms: Perspectives of Students and Professors. Daley LA, Wagner JK, Himmel TL, McPartland KA, Katsanis SH, Shriver MD, Royal CD, Genet Test Mol Biomarkers. 2013 Mar 28;. Abstract
Characterization of the standard and recommended CODIS markers. Katsanis SH, Wagner JK, J Forensic Sci. 2013 Jan;58 Suppl 1:S169-72. Abstract
A synonymous mutation in TCOF1 causes Treacher Collins syndrome due to mis-splicing of a constitutive exon. Macaya D, Katsanis SH, Hefferon TW, Audlin S, Mendelsohn NJ, Roggenbuck J, Cutting GR, Am J Med Genet A. 2009 Aug;149A(8):1624-7. Abstract
Developing the blueprint for a genetic testing registry. Javitt G, Katsanis S, Scott J, Hudson K, Public Health Genomics. 2010;13(2):95-105. Abstract
Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors. Kaufman DJ, Katsanis SH, Javitt GH, Murphy JA, Scott JA, Hudson KL, Clin Genet. 2008 Oct;74(4):367-73. Abstract
Public health. A case study of personalized medicine. Katsanis SH, Javitt G, Hudson K, Science. 2008 Apr 4;320(5872):53-4. Abstract
Biochemical analysis of cultured chorionic villi for the prenatal diagnosis of peroxisomal disorders: biochemical thresholds and molecular sensitivity for maternal cell contamination detection. Steinberg S, Katsanis S, Moser A, Cutting G, J Med Genet. 2005 Jan;42(1):38-44. Abstract
Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice.
Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Sabéran-Djoniedi D, Figarella-Branger D, Pellissier JF, Thomas PK, Fontés M, Hum Mol Genet. 1998 Mar;7(3):449-58. Abstract
Linkage analysis in a family with the Opitz GBBB syndrome refines the location of the gene in Xp22 to a 4 cM region. May M, Huston S, Wilroy RS, Schwartz C, Am J Med Genet. 1997 Jan 20;68(2):244-8. Abstract
A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M, N Engl J Med. 1996 Dec 26;335(26):1941-9. Abstract
Intra- and Interpopulation Genome Variation In Meloidogyne arenaria. Hiatt EE, Georgi L, Huston S, Harshman DC, Lewis SA, Abbott AG, J Nematol. 1995 Jun;27(2):143-52. Abstract